Hyperrab Injection, Solution
Product Images NDC 13533-318

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Hyperrab (NDC 13533-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 mL Carton (1mlcarton)

Label for HyperRAB 300 IU/mL injection, a rabies immune globulin (human) solution for infiltration and intramuscular injection. The label highlights that it is a sterile solution with 300 IU/mL potency, contains no preservatives, and is not made with natural rubber latex. It includes storage instructions, manufacturer Grifols Therapeutics LLC, and the NDC 13533-318-01.*

FDA Label Image

1 mL Vial (1mlvial)

Label for HyperRAB Rabies Immune Globulin (Human) injection, solution with strength of 300 IU/mL. The label indicates a single-dose vial of 1 mL, manufactured by Grifols USA, LLC. The label includes usage warnings, dosage instructions, lot number, and barcode.*

FDA Label Image

3 mL Carton (3mlcarton)

Label for HyperRAB 900 IU/3 mL Rabies Immune Globulin (Human) injection solution. The sterile injection contains 300 IU/mL rabies immune globulin for infiltration and intramuscular use. Label indicates no natural rubber latex or preservatives, and is manufactured by Grifols USA, LLC. NDC 13533-318-03.*

FDA Label Image

3 M Vial (3mlvial)

Label for HyperRAB Rabies Immune Globulin (Human) injection, 300 IU/mL (3 mL single-dose vial) by Grifols USA, LLC. The label includes dosage instructions and warnings emphasizing not to administer intravenously and to see directions before use. U.S. license and lot/expiration placeholders are also shown.*

FDA Label Image

5 mL Carton (5mlcarton)

HyperRAB 300 IU/mL injection solution, a rabies immune globulin (human) plasma derivative for infiltration and intramuscular use. The label shows a 5 mL single-dose vial containing 300 IU/mL, manufactured by Grifols USA, LLC. The packaging includes storage instructions, barcode, NDC 13533-318-05, and notes on product composition and handling.*

FDA Label Image

5 mL Vial (5mlvial)

Label for HyperRAB Rabies Immune Globulin (Human) 1500 IU/5 mL (300 IU/mL) injection, solution in a single-dose 5 mL vial. The label indicates the product is for infiltration and intramuscular use, supplied by Grifols Therapeutics LLC, USA. It includes dosage instructions and warnings not to inject intravenously.*

FDA Label Image

Figure 1 (Figure1)

A line graph illustrating mean rabies virus neutralizing antibody levels (IU/mL) with standard deviation over time in hours after a single 20 IU/kg dose of HyperRAB (300 IU/mL) administered via intramuscular injection. The x-axis represents time in hours up to 504 hours, and the y-axis shows antibody levels.*

FDA Label Image

Figure 2 (Figure2)

A chart titled 'Reciprocal of Anti-Rabies Virus Neutralizing Antibody Titer' showing antibody levels over 22 days for HYPERRAB 300 IU/mL (RIG-C) and HYPERRAB S/D 150 IU/mL (RIG-S/D) products. The Y-axis represents reciprocal titer values and the X-axis represents time in days, with data points comparing the two product types over the study period.*

FDA Label Image

Grifols (Grifols)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.